Synthaverse S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SVE.WA research report →
About the company
Based in Lublin, Poland, Synthaverse S. A. operates as a pharmaceutical enterprise, engaging in the manufacturing and distribution of a broad spectrum of medicinal products, medical apparatus, and laboratory reagents throughout Poland.
- CEO
- Jakub Winkler
- IPO
- 2011
- Employees
- 239
- HQ
- Lublin, PL
Price Chart
- Market Cap
- $203.44M
- P/E
- -8.73
- P/S
- 4.82
- P/B
- 1.68
- EV/EBITDA
- -24.88
- Div Yield
- 0.00%
- Gross Margin
- 49.68%
- Op Margin
- -55.66%
- Net Margin
- -54.51%
- ROE
- -18.68%
- ROIC
- -7.79%
- Revenue
- $42.01M · -41.46%
- Net Income
- $-19,932,000 · -364.00%
- EPS
- $-0.27 · -345.45%
- Op Income
- $-20,577,000
- FCF YoY
- 25.97%
- 52W High
- $5.40
- 52W Low
- $2.60
- 50D MA
- $3.08
- 200D MA
- $3.74
- Beta
- 0.16
- Avg Volume
- 60.42K
Get TickerSpark's AI analysis on SVE.WA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our SVE.WA coverage
Recent articles, reports, and earnings notes.
No research on SVE.WA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SVE.WA report →Similar companies
Peers in the same neighborhood.